BioSpace News Archive

Business

Crescendo Biologics to collaborate with world-leading oncology groups at the University of Oxford and the University of Surrey

Crescendo Biologics Ltd announces that it has signed collaborations with world-renowned oncology research groups at the University of Oxford and the University of Surrey.

September 18, 2019
·
5 min read
Deals

Investment Plan for Europe – Successful launch of Tech Transfer Fund “KHAN-I”

Khanu Management GmbH, a drug discovery focused fund management team, announces the successful launch of KHAN Technology Transfer Fund I GmbH & Co KG, based in Dortmund, Germany.

September 18, 2019
·
7 min read
Pharm Country

Oncoceutics Commemorates National Childhood Cancer Awareness Month

Oncoceutics, a clinical-stage drug discovery and development company, commemorates National Childhood Cancer Awareness Month this September and reiterates its support for children and all those affected by childhood cancer.

September 18, 2019
·
2 min read
Bio NC

Rho Named to Best Places to Work List by Triangle Business Journal for the Eighth Time

Rho announced that the Triangle Business Journal has named the company a winner of the Best Places to Work award in the Triangle.

September 18, 2019
·
1 min read
Deals

AML biotech Race Oncology (RAC) strengthens board with prominent biotech investor Dr Daniel Tillet

Race Oncology Limited is pleased to announce that prominent biotechnology investor and substantial Race shareholder, Dr Daniel Tillett, has joined the Board of Directors of Race Oncology Ltd.

September 18, 2019
·
2 min read
Santhera to Present Long-Term Data with Puldysa® (Idebenone) in Duchenne Muscular Dystrophy at Upcoming Medical Congresses

Santhera Pharmaceuticals will present data on the therapeutic effects of long-term treatment with Puldysa® in Duchenne muscular dystrophy at the forthcoming medical conferences of the European Paediatric Neurology Society, European Respiratory Society and World Muscle Society.

September 18, 2019
·
8 min read
Drug Development

Nordic Nanovector R&D Day unveils updates on several programmes

Nordic Nanovector ASA (OSE: NANO) will host an R&D day in Oslo.

September 18, 2019
·
8 min read
Deals

CMR Surgical raises £195 million ($240 million) in Series C financing

CMR Surgical Limited announces that it has raised £195 million ($240 million) to fully fund the global commercialisation of the business.

September 18, 2019
·
5 min read
Deals

CARB-X funds Procarta Biosystems to develop oligonucleotide-based antibiotics to combat life-threatening Gram-negative pathogens

CARB-X is awarding Procarta Biosystems, a UK-based biotech company, up to US$2.2 million in non-dilutive funding with the possibility of $7.0 million more if certain project milestones are met, to develop a new class of antibiotics to treat Gram-negative ESKAPE pathogens.

September 18, 2019
·
11 min read
Polyganics Achieves Positive 3-month Follow-up Data of ENCASE I, the First Clinical Trial for LIQOSEAL®

Polyganics, a medical technology company developing, manufacturing and commercializing bioresorbable medical devices, has announced positive data from its ENCASE I* clinical trial.

September 18, 2019
·
5 min read